title: [Hormone suppression therapy in benign nodular goiter].
abstract: Nodular goitre was detected in as many as 21 - 27% of the adult population in a non-endemic area. The most frequent therapeutic procedure is suppressive treatment with thyroxine. The author analyzes the results of prospective randomized, placebo controlled studies, which focused attention on the effectiveness of suppressive treatment. In the majority an inadequate effect was recorded. In the conclusion the author suggests an algorithm of suppressive treatment of nodular goitre and conditions after goitrectomy on account of nodular goitre.
authors.affiliation: Interní klinika IPVZ, Zlín, spolupracující centrum SZO pro studium diabetu.
authors.forename: Z
authors.initials: Z
authors.lastname: Málek
mesh_terms: D000328:Adult; D006044:Goiter, Nodular / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013972:Thyrotropin / Q000378:metabolism; D013974:Thyroxine / Q000627:therapeutic use*
chemical_list: D013972:Thyrotropin; D013974:Thyroxine